Assurant, Inc.
AIZ · NYSE
Analyst ratings
strong_buy · 6 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| July 8, 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | $310.00 |
| July 6, 2026 | Morgan Stanley | Maintains | Overweight | $300.00 |
| June 17, 2026 | Truist Securities | Maintains | Buy | $310.00 |
| May 26, 2026 | Piper Sandler | Maintains | Overweight | $290.00 |
| May 14, 2026 | Morgan Stanley | Upgrades | Overweight | $285.00 |
| May 13, 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | $270.00 |
| May 11, 2026 | UBS | Maintains | Buy | $274.00 |
| May 11, 2026 | Piper Sandler | Maintains | Overweight | $268.00 |
| May 7, 2026 | Truist Securities | Maintains | Buy | $290.00 |
| April 6, 2026 | Morgan Stanley | Maintains | Equal-Weight | $240.00 |
| February 12, 2026 | BMO Capital | Maintains | Outperform | $246.00 |
| February 12, 2026 | Truist Securities | Maintains | Buy | $280.00 |
| December 19, 2025 | Piper Sandler | Maintains | Overweight | $264.00 |
| November 20, 2025 | Keefe, Bruyette & Woods | Maintains | Outperform | $254.00 |
| November 17, 2025 | Morgan Stanley | Maintains | Equal-Weight | $248.00 |
| November 10, 2025 | UBS | Maintains | Buy | $257.00 |
| October 10, 2025 | Piper Sandler | Maintains | Overweight | $248.00 |
| October 8, 2025 | UBS | Maintains | Buy | $255.00 |
| October 7, 2025 | Morgan Stanley | Maintains | Equal-Weight | $232.00 |
Earnings sustainability and EPS growth trajectory
Assurant's Q1 2026 EPS of $5.95 significantly beat the consensus estimate of $5.29, and analysts forecast full-year EPS of $21.04. Morgan Stanley upgraded the stock to overweight, citing confidence in the company's earnings power and raising its price target to $285.00.
Wall Street Zen downgraded Assurant from a buy to a hold rating, signaling skepticism about whether the strong quarterly beat reflects a sustainable earnings trend or a one-time outperformance that may not be repeatable over the next 12 months.
Valuation and price target divergence
Truist Financial and Royal Bank of Canada each set a $310.00 price target on Assurant, representing meaningful upside from current trading levels near $280. These targets reflect confidence in continued revenue growth, which rose 11.3% year over year to $3.42 billion.
Weiss Ratings downgraded Assurant from a 'buy (a-)' to a 'buy (b+)' rating, and Keefe, Bruyette & Woods set a more conservative $270.00 price objective — well below other analyst targets — suggesting meaningful disagreement about how much upside remains at current price levels.
Capital allocation strategy and shareholder returns
Assurant's holding company liquidity stood at $836.0 million as of March 31, 2026, exceeding the minimum threshold by $611.0 million. The company repurchased 556,137 shares for $125.0 million and returned $169.0 million to shareholders in Q1 2026 alone, reinforcing investor confidence.
An EVP's sale of 2,000 shares shortly after the quarterly earnings release raises questions about insider confidence in the stock's near-term appreciation potential, potentially signaling that those closest to the company see limited upside despite the aggressive capital return program.